A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 388 participants.
Also called NCT01894568
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 388 participants
- Sponsor
- Registry
-
NCT01894568
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan, South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01894568. Randomized; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2015-04 (actual). Results posted on 2019-03-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Insulin Peglispro
- Intervention (Drug)
- Insulin Glargine
- Intervention (Drug)
- Oral Antihyperglycemic Medications (OAMs)
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01894568- Content hash
79103f0691ec0f19340502de69586c91f8a0bd14884b39889d37d94a446d364b